HAP Trading’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-86,500
Closed -$189K 1250
2022
Q4
$189K Sell
86,500
-24,800
-22% -$33.1K 0.02% 485
2022
Q3
$193K Buy
111,300
+48,800
+78% +$128K 0.01% 633
2022
Q2
$162K Buy
62,500
+15,000
+32% +$39.9K 0.01% 776
2022
Q1
$133K Sell
47,500
-65,300
-58% -$189K 0.01% 950
2021
Q4
$389K Sell
112,800
-14,200
-11% -$87.1K 0.01% 771
2021
Q3
$279K Buy
127,000
+15,800
+14% +$135K 0.01% 898
2021
Q2
$192K Buy
111,200
+59,100
+113% +$580K 0.01% 1025
2021
Q1
$189K Buy
52,100
+38,000
+270% +$429K 0.01% 786
2020
Q4
$16K Buy
+14,100
New +$157K ﹤0.01% 1776

Other funds holding CLOV

HAP Trading's CLOV Position: Q4 2022 in Review

HAP Trading sold out of Clover Health Investments (CLOV) in Q4 2022, closing a stake of 138,733 shares — an estimated $185K sold.

HAP Trading first reported a position in CLOV in Q4 2020 and held it in 2 quarters. The position peaked at $512K in Q4 2020. 175 funds tracked by Wall St. Rank hold CLOV as of Q4 2022.

  • HAP Trading reported no remaining Clover Health Investments position as of Q4 2022 after selling out during the quarter.
  • HAP Trading sold 138,733 Clover Health Investments shares in Q4 2022, an estimated $185K.
  • HAP Trading first reported a position in Clover Health Investments in Q4 2020 and held it in 2 quarters.
  • HAP Trading's Clover Health Investments position peaked at $512K in Q4 2020.
  • 175 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2022.

Based on HAP Trading's 13F filing for Q4 2022, filed 14 Feb 2023.